Mark Lawrence is a Cardiology physician affiliated with Baylor Scott & White Medical Center - Temple. OpenAlex indexes 26 publications with 304 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2401 S 31st St
Temple, TX 765080001
Telephone
254-724-2111Provider last certified this registry record 2 Jul 2020.
Clinical trials
- Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides
Sponsor: Indiana University
- Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
Sponsor: Memorial Sloan Kettering Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202525 payments
- Edwards Lifesciences CorporationProgram year202523 payments
- ABIOMEDProgram year202532 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.8%Beta blocker19.5%Metoprolol Succinate41%Carvedilol32%Metoprolol Tartrate17%Atenolol6%Sotalol5%Part D<11 patientsStatin18.8%Atorvastatin Calcium57%Rosuvastatin Calcium40%Simvastatin4%Part D<11 patients+ 14 more classes in this area
Blood & clotting
27.3%P2Y12 inhibitor14.8%Clopidogrel72%Brilinta28%Part D≥98 patientsFactor Xa inhibitor9.9%Eliquis86%Xarelto15%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.9%Potassium supplement1.6%Potassium Chloride100%Part D≥19 patientsGLP-1 receptor agonist0.6%Ozempic100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Simplified percutaneous VA ECMO decannulation using the MANTA vascular closure device: Initial US experience
Journal of Cardiac Surgery
2019 - Acute stroke intervention after transcatheter aortic valve replacement
Baylor University Medical Center Proceedings
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Tavilla, MD, PhD
Baylor Scott & White Medical Center - Temple
Tariq Shafi, MD
Baylor Scott & White Medical Center - Temple
Shekhar Ghamande, MD
Baylor Scott & White Medical Center - Temple
Lazaros Nikolaidis, MD
Baylor Scott & White Medical Center - Temple
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”